Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05523622 · ClinicalTrials.gov registry record · NA

Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices

A NA study of Glaucoma, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
1
Study location

NCT05523622 is a NA study of Glaucoma that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 300 participants, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05523622, a NA study of Glaucoma, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
1
Study location

Study Summary

We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.

Conditions Studied

Interventions

  • DEVICE Tono-Vera tonometer
  • DEVICE Goldman Applanation Tonometry

Study Locations (1)

New York

  • Ross Eye Institute - Buffalo

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2022-08-01
Est. Completion 2025-12-31
Phase NA

What the Registry Record Tells You About NCT05523622

The ClinicalTrials.gov registry entry for NCT05523622 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 907-participant average among 92 other Glaucoma trials with a reported enrollment target (67% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Tono-Vera tonometer is the first listed.

NCT05523622 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05523622 about?

NCT05523622 is a clinical study titled "Comparison of Intraocular Pressure Measurement With the Novel TonoVera Device With Other Commonly Used Devices". We are testing the accuracy of Reichert's Tono-Vera tonometer by comparing measurements of IOP with this device and measurements with other commonly-used tonometers, including Goldmann Applanation and iCare.

What is the current status of trial NCT05523622?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2022-08-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05523622 study?

This clinical trial studies the following conditions: Glaucoma.

What interventions are being tested in trial NCT05523622?

The interventions under investigation include: Tono-Vera tonometer (DEVICE), Goldman Applanation Tonometry (DEVICE).

Who is sponsoring clinical trial NCT05523622?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05523622 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glaucoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.